M*7
2 楼
下看2刀
S*P
3 楼
昨日之星就这样陨落了
j*9
4 楼
这公司会倒闭么？有自己的产品么？
S*P
5 楼
有：
PROVENGE® (sipuleucel-T) is the first autologous cellular immunotherapy
to receive FDA approval for the treatment of asymptomatic or minimally
symptomatic metastatic castrate resistant prostate cancer. PROVENGE is
designed to induce an immune response against prostate cancer.
【在 j****9 的大作中提到】
: 这公司会倒闭么？有自己的产品么？
PROVENGE® (sipuleucel-T) is the first autologous cellular immunotherapy
to receive FDA approval for the treatment of asymptomatic or minimally
symptomatic metastatic castrate resistant prostate cancer. PROVENGE is
designed to induce an immune response against prostate cancer.
【在 j****9 的大作中提到】
: 这公司会倒闭么？有自己的产品么？
相关阅读